Paraganglioma overview: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(16 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Paraganglioma}}
{{Paraganglioma}}
{{CMG}} {{AE}} {{AAM}}
{{CMG}} {{AE}}
 
==Overview==
==Overview==
Paraganglioma is a rare [[neoplasm]] that can be found along the spinal cord, in the abdomen, thorax, head and neck. They are usually considered [[benign]]. However, in about 3% of cases they are [[malignant]] and have the ability to [[metastasis|metastasize]]. Symptoms of paraganglioma may include [[dysphagia]], [[dizziness]], [[tinnitus]] and [[hearing loss]]. Complete surgical removal results in cure. Paragangliomas are still sometimes called glomus tumors (not to be confused with [[glomus tumor]]s of the skin) and chemodectomas, but paraganglioma is the currently accepted and preferred term.


Paragangliomas are found predominantly in the abdomen (85%), other sites include thorax (12%), head and neck (3%). Most occur as single tumors. When they occur in multiple sites they are usually found as a part of a heritable syndrome, such as [[multiple endocrine neoplasia]] types II-A, II-B, and ''[[SDH]]'' related mutations. Symptoms of paraganglioma include [[dysphagia]], [[dizziness]], and hearing problems. MRI is helpful in localization of  paraganglioma which demonstrates a high signal mass.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_94_toc</ref>
==Historical Perspective==
Surgery is the mainstay of treatment for paraganglioma.


==Historical perspective==
Glomus tumor name formerly (and incorrectly) used for paraganglioma.
==Classification==
==Classification==
Paraganglioma may be classified into several subtypes based on the site of origin and having a neural cell line.
 
==Pathophysiology==
==Pathophysiology==
On gross pathology, sharply circumscribed polypoid red vascular masses with the firm to rubbery in consistency are characteristic of paragangliomas. On microscopic inspection, the tumor cells are readily recognized.  Individual tumor cells are polygonal to oval and are arranged in distinctive cell balls, called Zellballen.  These cell balls are separated by fibrovascular [[stroma]] and surrounded by
 
sustentacular cells.
==Causes==
==Causes==
There are no established causes for paraganglioma, approximately 25% of cases are inherited.
 
==Differentiating Paraganglioma From Other Diseases==
==Differentiating Xyz from Other Diseases==
Paraganglioma must be differentiated from [[carcinoid tumor]], neuroendocrine carcinoma, medullary carcinoma of the thyroid, middle ear [[adenoma]], and [[meningioma]].
 
==Epidemiology and Demographics==
==Epidemiology and Demographics==
Paraganglioma is a rare disease, familial paragangliomas account for approximately 25% of cases and occur at an earlier age.
 
==Complication==
==Risk Factors==
Complications associated with paraganglioma may include [[Hoarseness]], [[Dysphagia]], [[Hearing loss]], and [[Facial paralysis]].
 
==Screening==
 
==Natural History, Complications, and Prognosis==
 
 
==Diagnosis==
==Diagnosis==
===Staging===
===Diagnostic Study of Choice===
There is no established system for the staging of paraganglioma.
===Symptoms===
Symptoms of paraganglioma include [[dysphagia]], [[dizziness]], [[tinnitus]] and [[hearing loss]].


===Physical Examination Finding===
===History and Symptoms===


Common physical examination findings of paragangliomas include painless [[neck masses|neck mass]], [[hearing loss]], and [[tympanic membrane|red tympanic membrane]].
===Physical Examination===


===CT===
===Laboratory Findings===
 
===Electrocardiogram===
 
===X-ray===
 
===Echocardiography and Ultrasound===
 
===CT scan===


CT scan is helpful in localization of  paraganglioma.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_94_toc</ref>
===MRI===
===MRI===
MRI is helpful in localization of  paraganglioma which demonstrates a high signal mass.<ref name="cancergov"> National Cancer Institute. Physician Data Query Database 2015. http://www.cancer.gov/types/pheochromocytoma/hp/pheochromocytoma-treatment-pdq#link/_94_toc</ref>
 
===Other Imaging Studies===
===Other Imaging Findings===
<sup>123</sup>I-metaiodobenzylguanidine (MIBG) scintigraphy coupled with CT imaging can be used for the diagnosis of paragnglioma.
 
===Other Diagnostic Studies===
 
==Treatment==
==Treatment==
===Medical Therapy===
===Medical Therapy===
Pharmacological medical therapies for paraganglioma include alpha blockers, beta blockers, and chemotherapy.
 
=== Interventions ===
 
===Surgery===
===Surgery===
Surgery is the mainstay of treatment for paraganglioma.
 
===Primary Prevention===
 
===Secondary Prevention===
 
==References==
==References==
{{reflist|2}}
{{reflist|2}}
{{Epithelial neoplasms}}
 
{{WikiDoc Help Menu}}
[[Category:Up-To-Date]]
{{WikiDoc Sources}}
[[Category:Oncology]]
[[Category:Disease]]
[[Category:Medicine]]
[[Category:Types of cancer]]
[[Category:Neurology]]
[[Category:Mature chapter]]
[[Category:Endocrinology]]

Latest revision as of 23:35, 29 July 2020

Paraganglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paraganglioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paraganglioma overview On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paraganglioma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paraganglioma overview

CDC on Paraganglioma overview

Paraganglioma overview in the news

Blogs on Paraganglioma overview

Directions to Hospitals Treating Paraganglioma

Risk calculators and risk factors for Paraganglioma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Xyz from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

References